Literature DB >> 30400090

Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease.

Monia Cabinio1, Marina Saresella1, Federica Piancone1, Francesca LaRosa1, Ivana Marventano1, Franca Rosa Guerini1, Raffaello Nemni2,3, Francesca Baglio1, Mario Clerici1,3.   

Abstract

BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative condition characterized by memory impairment and general decrease in cognitive functions and daily living competences, that leads to a complete loss of autonomy. The pathogenesis of AD is characterized by the deposition of amyloid-β plaques (Aβ plaques) and neurofibrillary tangles, initially involving cortical and hippocampal structures, and neuroinflammation. To date, no studies have investigated the topological association between neuroinflammation and hippocampal shape in AD.
OBJECTIVE: The aim of the present study is to assess the association between hippocampal shape, cognitive profile, and neuroinflammation in a group of AD patients in the mild stage of the disease.
METHODS: Thirty-one patients with typical onset AD (mild stage) underwent MRI examination (1.5T scanner); hippocampal structures were segmented using a vertex-wise analysis (FSL-FIRST). Immune parameters were evaluated on peripheral blood mononuclear cells by flow-cytometry. Correlation analyses were performed between hippocampal shape and both cognitive profile (ADAS-Cog and MMSE scores), and neuro-inflammatory variables (i.e., circulating monocytes, cytokines).
RESULTS: Statistically significant correlations (p < 0.05FWE) between right hippocampal shape and cognitive measurements and between left hippocampal shape and inflammatory indices were detected. The hippocampal field mostly involved was the lateral portion of bilateral hippocampi, mainly overlapping with Cornu Ammonis, extending along the entire longitudinal axis.
CONCLUSIONS: A topological relationship between hippocampal atrophy and both cognitive profile and neuroinflammation is found; the association with neuroinflammatory indices is in line with the pattern of AD-associated neuronal death, whereas the association with cognitive test might account for residual cognitive functions.

Entities:  

Keywords:  Alzheimer’s disease; Magnetic Resonance Imaging (MRI); brain; flow cytometry; hippocampus; inflammation

Mesh:

Year:  2018        PMID: 30400090     DOI: 10.3233/JAD-180250

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  9 in total

1.  IL-33 and its decoy sST2 in patients with Alzheimer's disease and mild cognitive impairment.

Authors:  Marina Saresella; Ivana Marventano; Federica Piancone; Francesca La Rosa; Daniela Galimberti; Chiara Fenoglio; Elio Scarpini; Mario Clerici
Journal:  J Neuroinflammation       Date:  2020-06-06       Impact factor: 8.322

2.  Subcortical amyloid load is associated with shape and volume in cognitively normal individuals.

Authors:  Shady Rahayel; Christian Bocti; Pénélope Sévigny Dupont; Maude Joannette; Marie Maxime Lavallée; Jim Nikelski; Howard Chertkow; Sven Joubert
Journal:  Hum Brain Mapp       Date:  2019-05-30       Impact factor: 5.038

3.  Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer's disease progression based on the "brain-gut" axis through multiple integrated omics.

Authors:  Xinru Gu; Junyi Zhou; Yanyan Zhou; Hongjie Wang; Nan Si; Wei Ren; Wei Zhao; Xiaorui Fan; Wenya Gao; Xiaolu Wei; Jian Yang; Baolin Bian; Haiyu Zhao
Journal:  Alzheimers Res Ther       Date:  2021-02-12       Impact factor: 6.982

4.  Plasma MCP-1 and changes on cognitive function in community-dwelling older adults.

Authors:  Juan Luis Sanchez-Sanchez; Kelly V Giudici; Sophie Guyonnet; Julien Delrieu; Yan Li; Randall J Bateman; Angelo Parini; Bruno Vellas; Philipe de Souto Barreto
Journal:  Alzheimers Res Ther       Date:  2022-01-07       Impact factor: 6.982

5.  Monocytic Subsets Impact Cerebral Cortex and Cognition: Differences Between Healthy Subjects and Patients With First-Episode Schizophrenia.

Authors:  Song Chen; Fengmei Fan; Fang-Ling Xuan; Ling Yan; Meihong Xiu; Hongzhen Fan; Yimin Cui; Ping Zhang; Ting Yu; Fude Yang; Baopeng Tian; L Elliot Hong; Yunlong Tan; Li Tian
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

6.  The unique effect of TDP-43 on hippocampal subfield morphometry and cognition.

Authors:  Ashley Heywood; Jane Stocks; Julie A Schneider; Konstantinos Arfanakis; David A Bennett; Mirza Faisal Beg; Lei Wang
Journal:  Neuroimage Clin       Date:  2022-07-25       Impact factor: 4.891

7.  Ultrastructural characterization of dark microglia during aging in a mouse model of Alzheimer's disease pathology and in human post-mortem brain samples.

Authors:  Marie-Kim St-Pierre; Micaël Carrier; Fernando González Ibáñez; Eva Šimončičová; Marie-Josée Wallman; Luc Vallières; Martin Parent; Marie-Ève Tremblay
Journal:  J Neuroinflammation       Date:  2022-09-27       Impact factor: 9.587

Review 8.  Promising Intervention Approaches to Potentially Resolve Neuroinflammation And Steroid Hormones Alterations in Alzheimer's Disease and Its Neuropsychiatric Symptoms.

Authors:  Catia Scassellati; Antonio Carlo Galoforo; Ciro Esposito; Miriam Ciani; Giovanni Ricevuti; Cristian Bonvicini
Journal:  Aging Dis       Date:  2021-08-01       Impact factor: 6.745

Review 9.  Preserved Consciousness in Alzheimer's Disease and Other Dementias: Caregiver Awareness and Communication Strategies.

Authors:  Alison Warren
Journal:  Front Psychol       Date:  2021-12-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.